A shortened, two-hour infusion of the GP IIb/IIIa inhibitor eptifibatide following nonemergency PCI is just as effective as the standard 18-hour infusion of the drug and is probably safer, according to a new study. Heartwire
New research shows that a history of hypertension increases the risk for mild cognitive impairment, suggesting that prevention and management of hypertension may lower the risk for cognitive decline. Medscape Medical News
A review of the latest data on the long-term use of prostanoids and combination therapy in the treatment of pulmonary hypertension. Medscape Pulmonary Medicine
With the Olympics in Beijing, China, rapidly approaching, attention is now turned to some of the medical and health challenges facing the city, including some of the cardiovascular concerns facing the athletes and the long-term consequences of changing risk factors for the population at large. Heartwire
